Paper16420554
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
Miyakis S and 14 others. J Thromb Haemost, 2006. Cited by 5,307 papers, by iCite.
Cite this record
ConductScience Library. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Papers, record 16420554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16420554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiphospholipid Syndrome | Major topic |
| Antibodies, Antiphospholipid | |
| Female | |
| Heart Diseases | |
| Humans | |
| Kidney Diseases | |
| Nervous System Diseases | |
| Pregnancy | |
| Pregnancy Complications | |
| Prognosis | |
| Risk Factors | |
| Skin Diseases | |
| Thrombocytopenia |
Source PubMed
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02295475 | Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome | Background | ClinicalTrials.gov | |
| NCT03152058 | IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy | Background | ClinicalTrials.gov | |
| NCT04754698 | COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS | Background | ClinicalTrials.gov | |
| NCT05995600 | Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE | Background | ClinicalTrials.gov |
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 16869832 | Clinical relevance of the recent update of the classification criteria for definite antiphospholipid syndrome: an obstetric medicine clinic series of 107 patients. | https://conductscience.org/library/papers/16869832 | PubMed |
| Comment in | 18625658 | Some concerns about the Sydney criteria for antiphospholipid syndrome. | https://conductscience.org/library/papers/18625658 | PubMed |
Cited by2,108
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5,307 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953482 | Microbiota-host interactions: key mechanisms linking periodontitis and systemic lupus erythematosus. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42953482 | PubMed |
| 42948279 | Large, Life-Threatening Right Ventricular and Pulmonary Artery Thrombus Revealing Antiphospholipid Syndrome: The Role of Risk Stratification and Thrombolytic Therapy. | Cureus | 2026 | https://conductscience.org/library/papers/42948279 | PubMed |
| 42941518 | Clinical Phenotype, Treatment Exposure, Treat-to-Target Status, and Longitudinal Outcomes in Juvenile-Onset Systemic Lupus Erythematosus: A Single-Center Retrospective Cohort Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/42941518 | PubMed |
| 42939997 | Towards a Novel Diagnostic Tool for Autoimmune Rheumatic Diseases: Classification of SLE Using FTIR Spectroscopy and Machine Learning. | Biomedicines | 2026 | https://conductscience.org/library/papers/42939997 | PubMed |
| 42931417 | SARS-CoV-2-Specific IgG Levels Are Inversely Associated with ACPA-Reactive Pathological and Natural Autoantibody Profiles in Residual Diagnostic Samples. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42931417 | PubMed |
| 42928933 | Sudden Onset Occipital Headache as a Presenting Feature of Ischaemic Stroke. | Cureus | 2026 | https://conductscience.org/library/papers/42928933 | PubMed |
| 42924065 | Superior Ophthalmic Vein Thrombosis Presenting as Isolated Headache: A Case Report. | Case Rep Neurol | 2026 | https://conductscience.org/library/papers/42924065 | PubMed |
| 42912010 | Differences in the clinical profile between isolated lupus anticoagulant and triplepositive antiphospholipid antibody profiles in primary antiphospholipid syndrome. | Einstein (Sao Paulo) | 2026 | https://conductscience.org/library/papers/42912010 | PubMed |
| 42904261 | Antiphospholipid Syndrome as an Under-Recognized Cause of Ischemic Stroke in Older Adults: A Retrospective Case Series. | Cureus | 2026 | https://conductscience.org/library/papers/42904261 | PubMed |
| 42892939 | Beyond thrombosis: a scoping review of patient-reported outcomes in antiphospholipid syndrome. | Blood Vessel Thromb Hemost | 2026 | https://conductscience.org/library/papers/42892939 | PubMed |
| 42886731 | Identifying diagnostic testing gaps for antiphospholipid syndrome within a single healthcare system. | PLoS One | 2026 | https://conductscience.org/library/papers/42886731 | PubMed |
| 42881855 | Thrombophilia Testing After VTE and in Related Clinical Contexts: Is It Necessary, and Does It Change Management? Appraisal of Evidence, Guidelines, and Clinical Yield. | J Clin Med | 2026 | https://conductscience.org/library/papers/42881855 | PubMed |
| 42876815 | Pentasystem embolism associated with transient antiphospholipid antibodies in severe M. pneumoniae pneumonia: a "Dual-Hit" case report and systematic review. | Front Immunol | 2026 | https://conductscience.org/library/papers/42876815 | PubMed |
| 42873398 | Health Information-seeking Behavior in Patients with Antiphospholipid Syndrome: A Scoping Review with Original Data. | Curr Rheumatol Rep | 2026 | https://conductscience.org/library/papers/42873398 | PubMed |
| 42853856 | Systematic review and network meta-analysis of performance of the Sapporo criteria, the Revised Sapporo criteria, and the 2023 ACR/EULAR APS classification criteria for patients with antiphospholipid syndrome: A protocol. | PLoS One | 2026 | https://conductscience.org/library/papers/42853856 | PubMed |
| 42846571 | Non-thrombotic manifestations in pediatric patients with persistent antiphospholipid antibodies. A Mexican tertiary center case series. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42846571 | PubMed |
| 42834151 | Antiphospholipid syndrome: epidemiology and outcomes in the evolving criteria era. | Nat Rev Rheumatol | 2026 | https://conductscience.org/library/papers/42834151 | PubMed |
| 42827817 | Reclassification of obstetric antiphospholipid syndrome under the 2023 ACR/EULAR criteria: risk of under-recognition in patients with non-criteria antibodies and clinical implications. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42827817 | PubMed |
| 42821147 | Serum protocadherin 18 as a potential biomarker for antiphospholipid syndrome: a case-control study. | Rheumatol Int | 2026 | https://conductscience.org/library/papers/42821147 | PubMed |
| 42807612 | Prevalence and Predictors of Hypercoagulable Disorders in Patients With Concomitant Acute Limb Ischemia and Ischemic Stroke: A Cross-Sectional Study. | Cureus | 2026 | https://conductscience.org/library/papers/42807612 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16420554
GET https://conductscience.org/api/papers/v1/16420554/cited_by?page=2